Table 2 Comparison between group A (no. = 75), group B (no. = 125), group C (no. = 85), and group D (no. = 15) regarding findings
From: Prognostic significance of COVID-19 MSCT chest findings on short-term disease progression
Findings | Group A | Group B | Group C | Group D | Test value* | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | |||
GGO | 75 | 100.0% | 125 | 100.0% | 85 | 100.0% | 15 | 100.0% | NA | NA |
Consolidations | 5 | 6.7% | 30 | 24.0% | 38 | 44.7% | 13 | 86.7% | 54.452 | 0.001 |
Nodules | 23 | 30.7% | 18 | 14.4% | 5 | 5.9% | 2 | 13.3% | 18.796 | 0.001 |
Septal thickening | 35 | 46.7% | 95 | 76.0% | 82 | 96.5% | 15 | 100.0% | 59.069 | 0.001 |
Crazy pavings | 0 | 0.0% | 3 | 2.4% | 19 | 22.4% | 10 | 66.7% | 79.468 | 0.001 |
Fibrotic bands | 14 | 18.7% | 55 | 44.0% | 67 | 78.8% | 15 | 100.0% | 74.490 | 0.001 |
Lymphadenopathy | 0 | 0.0% | 0 | 0.0% | 3 | 3.5% | 0 | 0.0% | 7.665 | 0.043 |